These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797 [TBL] [Abstract][Full Text] [Related]
8. Sevelamer: where are the data? McCarron DA Kidney Int; 2003 Dec; 64(6):2329; author reply 2329-30. PubMed ID: 14633168 [No Abstract] [Full Text] [Related]
9. Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders. Sturtevant JM; Hawley CM; Reiger K; Johnson DW; Campbell SB; Burke JR; Bofinger A; Isbel NM Nephrology (Carlton); 2004 Dec; 9(6):406-13. PubMed ID: 15663645 [TBL] [Abstract][Full Text] [Related]
10. Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients. Marco MP; Muray S; Betriu A; Craver L; Belart M; Fernández E Nephron; 2002 Oct; 92(2):499-500. PubMed ID: 12218343 [No Abstract] [Full Text] [Related]
11. [Evolution in vitamin D treatment after debut of sevelamer hydrochloride in chronic renal failure patients]. Suzuki M Clin Calcium; 2004 Sep; 14(9):60-3. PubMed ID: 15577112 [TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis. Nolan CR; Qunibi WY Kidney Int Suppl; 2005 Jun; (95):S13-20. PubMed ID: 15882308 [TBL] [Abstract][Full Text] [Related]
13. Drug interaction between sevelamer and cyclosporin. Guillen-Anaya MA; Jadoul M Nephrol Dial Transplant; 2004 Feb; 19(2):515. PubMed ID: 14736993 [No Abstract] [Full Text] [Related]
14. Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study. Sadek T; Mazouz H; Bahloul H; Oprisiu R; El Esper N; El Esper I; Boitte F; Brazier M; Moriniere P; Fournier A Nephrol Dial Transplant; 2003 Mar; 18(3):582-8. PubMed ID: 12584283 [TBL] [Abstract][Full Text] [Related]
15. [Front line of management of hyperphosphatemia in hemodialysis patients]. Yumita S Clin Calcium; 2004 May; 14(5):771-7. PubMed ID: 15577041 [TBL] [Abstract][Full Text] [Related]
16. Treatment with sevelamer decreases bicarbonate levels in peritoneal dialysis patients. Borràs M; Marco MP; Fernández E Perit Dial Int; 2002; 22(6):737-8. PubMed ID: 12556084 [No Abstract] [Full Text] [Related]
17. Drug interaction between sevelamer and cyclosporin. Wauters JP; Uehlinger D; Marti HP Nephrol Dial Transplant; 2005 Mar; 20(3):660-1; author reply 661. PubMed ID: 15795949 [No Abstract] [Full Text] [Related]
18. Hyperphosphataemia and treatment with sevelamer in haemodialysis patients. Cizman B Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v47-9. PubMed ID: 12817070 [TBL] [Abstract][Full Text] [Related]
19. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Katsumata K; Kusano K; Hirata M; Tsunemi K; Nagano N; Burke SK; Fukushima N Kidney Int; 2003 Aug; 64(2):441-50. PubMed ID: 12846739 [TBL] [Abstract][Full Text] [Related]
20. [Mechanism and therapy of vascular calcification]. Hara S; Yokoyama K Clin Calcium; 2004 May; 14(5):752-5. PubMed ID: 15577037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]